<DOC>
	<DOCNO>NCT01015066</DOCNO>
	<brief_summary>This study design determine relative effectiveness buprenorphine/naloxone ( Suboxone ) pharmacotherapy versus naltrexone pharmacotherapy treatment retention , relapse prevention opioid crave reduction among opioid-dependent adolescent young adult . The investigator hypothesize naltrexone treatment effective buprenorphine/naloxone treatment outcome .</brief_summary>
	<brief_title>Comparison Buprenorphine/Naloxone With Naltrexone Opioid Dependent Adolescents</brief_title>
	<detailed_description>Context : Standard treatment opioid dependence adolescent detoxification counseling , result relapse 20-50 % patient . Alternative medical treatment include buprenorphine naltrexone well investigated adolescent young adult . Buprenorphine previously show effective treatment opioid dependence adolescent one study United States compare detoxification . Although naltrexone treatment result low compliance adult , effective combination strong social support network exist adolescent live least 1 parent/guardian . Objective : To compare efficacy buprenorphine/naloxone pharmacotherapy naltrexone pharmacotherapy treatment retention , relapse prevention crave reduction among opioid-addicted adolescent young adult . Design : 2-arm Randomized Comparative Effectiveness Pharmacotherapy Clinical Trial . Setting : The study conduct outpatient treatment facility Participants : The participant 1 ) 16-25 year old , 2 ) clear evidence substance use disorder opioid dependence , 3 ) live least one parent . Baseline data collection : Data collect baseline include ( example ) , demographic ( age , gender , race ) , substance use history ( type substance use , duration use , route abuse ) , co-existing medical problem ( seizure , hepatitis C ) , prior mental health problem ( prior treatment , diagnosis ) , prior substance abuse treatment ( outpatient , inpatient ) , socioeconomic variable ( educational level , occupation , employment history ) , criminal history ( number arrest conviction , total amount time spend jail prison ) , family history ( first degree relative substance use disorder ) score psychometric test ( DAST , opioid crave score ) . Outcome data : Four main outcome examine : Retention treatment , self-reported opioid craving , self-reported drug use urine toxicology confirmation . Retention treatment ( 1-180 day ) measure date participant last see study personnel date participant complete study follow date enrollment . Opioid carve ( 1-10 ) measure 10 point visual analog scale . Self-reported drug use ( day first use percent day abstinent ) measure time line follow back . Urine toxicology ( yes/no ) determine baseline monthly 1 , 2 , 3 , 4 , 5 , 6 month follow-up . Data analysis : Outcome variable compare two group use t-tests chi-square test appropriate . A Kaplan-Myer survival analysis use describe participant participation . Predictors poor outcome identify use case-control design poor outcome ( `` case '' ) compare successful outcome ( `` control '' ) use multivariate technique ( logistic regression ) .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Clinical Diagnosis Opiate Dependence Successful completion detoxification answer 9 10 question correctly test understand study unable pay medication live parent/guardian inability patient and/or parent give consent major cooccurring psychiatric disorder exist medical condition would interfere treatment use CNS depressant pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>drug dependence</keyword>
	<keyword>substance abuse</keyword>
	<keyword>substance use disorder</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>naltrexone</keyword>
	<keyword>adolescent</keyword>
</DOC>